Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2-MALT1 in MALT lymphoma.
about
API2-MALT1 oncoprotein promotes lymphomagenesis via unique program of substrate ubiquitination and proteolysisThe paracaspase MALT1: biological function and potential for therapeutic inhibitionMolecular Pathogenesis of MALT LymphomaThe paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling.The Paracaspase MALT1.Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.Elevated prevalence of Helicobacter species and virulence factors in opisthorchiasis and associated hepatobiliary disease.MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression.Genetic landscape and deregulated pathways in B-cell lymphoid malignancies.Cellular-level characterization of B cells infiltrating pulmonary MALT lymphoma tissues.Differing Requirements for MALT1 Function in Peripheral B Cell Survival and Differentiation.Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma.Autocleavage of the paracaspase MALT1 at Arg-781 attenuates NF-κB signaling and regulates the growth of activated B-cell like diffuse large B-cell lymphoma cells.The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex
P2860
Q26765188-C90AEBA9-DF99-4B73-8DA7-E8826A64F953Q26778357-140D5120-76F3-42A3-91F0-D244B85CC94EQ26825394-EB7525CA-81E2-4E11-99A0-2FBF3EEE5555Q34500164-28BBA0E9-B1F2-46EE-9D6B-2957EA8F467DQ36563807-86BABF2A-1CED-4F43-908C-B99A2A7B6F2BQ36988095-D029ED74-A84C-4B42-8814-0683510B144FQ37642847-F4A63246-AE62-415D-8153-F3B1DF00ECB7Q38495157-D74F231A-9D95-4D2F-9859-6C0AFF114CC3Q38669131-FC1AB3A5-E08E-4FE4-A271-3DA793CB8D32Q38947816-D1A40092-FC51-4E63-A7C7-703F9B2E9FACQ39056717-F3A3B683-D6D0-492E-845A-43CEE1303A73Q47119181-F62175C0-BA52-4B3A-8883-286B757575DEQ55449626-18F8477B-C009-4D9C-8678-14313C7352B9Q57072726-2AAEDACD-1E60-4CAE-B6A9-F8A0C092DCF4
P2860
Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2-MALT1 in MALT lymphoma.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Conversion of the LIMA1 tumour ...... y API2-MALT1 in MALT lymphoma.
@ast
Conversion of the LIMA1 tumour ...... y API2-MALT1 in MALT lymphoma.
@en
Conversion of the LIMA1 tumour ...... y API2-MALT1 in MALT lymphoma.
@nl
type
label
Conversion of the LIMA1 tumour ...... y API2-MALT1 in MALT lymphoma.
@ast
Conversion of the LIMA1 tumour ...... y API2-MALT1 in MALT lymphoma.
@en
Conversion of the LIMA1 tumour ...... y API2-MALT1 in MALT lymphoma.
@nl
prefLabel
Conversion of the LIMA1 tumour ...... y API2-MALT1 in MALT lymphoma.
@ast
Conversion of the LIMA1 tumour ...... y API2-MALT1 in MALT lymphoma.
@en
Conversion of the LIMA1 tumour ...... y API2-MALT1 in MALT lymphoma.
@nl
P2093
P2860
P50
P356
P1476
Conversion of the LIMA1 tumour ...... by API2-MALT1 in MALT lymphoma
@en
P2093
Cory M Hogaboam
Linda M McAllister-Lucas
Ming-Qing Du
Peter C Lucas
P2860
P2888
P356
10.1038/NCOMMS6908
P577
2015-01-08T00:00:00Z
P5875
P6179
1019790371